Objectives: This study considers susceptibility test results obtained over a 6 month period for Enterobacteriaceae that caused urinary tract infections (UTIs) in the Cork region of Ireland and uses these results to examine the suitability of Irish empirical treatment guidelines.
Introduction
Urinary tract infections (UTIs) are one of the most common types of infection encountered by medical practitioners. 1 Given the current high levels of antimicrobial intervention for the treatment of suspected UTIs, it is likely that the aetiological agents represent an important reservoir of antimicrobial resistance genes. 2 Members of the Enterobacteriaceae family are the predominant aetiological agents of UTIs and associated antimicrobial susceptibility testing (AST) profiles are used to guide empirical treatment guidelines. 3 Herein, we examine the rates of antimicrobial resistance to a panel of commonly recommended empirical treatment options for Enterobacteriaceae isolates. Furthermore, with reference to previous studies, we consider the appropriateness of a set of local empirical treatment guidelines in light of the antimicrobial resistance rates observed.
Methods

Ethics
Ethics approval was granted for this study by the Laboratory Medicine Research Overview Forum, Cork University Hospital, on 18 March 2016.
Laboratory investigation
All urine samples received for laboratory investigation by the Microbiology Laboratory at Cork University Hospital (CUH) during a 6 month period, 1 April to 30 September 2016, were included in this study. No additional selection criteria were used and this study reflects all significant isolates received during this 6 month period. AST profiles for samples resulting in significant growth of Enterobacteriaceae were obtained using the EUCAST disc diffusion method and associated interpretation guidelines for 2016 (version 6.0). 4 Significant growth was defined as pure growth of 
Data analysis
Information relating to these samples was collected from the Laboratory Information System at CUH using the IBM Cognos Analytics Series 7 Impromptu 7.5.0 analytical interrogation tool. Deduplication was conducted and all personal information was anonymized. Data analysis was completed using Microsoft Office Excel 2007 package for Windows (version 12) .
Results
During the study period the CUH Microbiology Laboratory received 55 942 urine samples for UTI investigation from a catchment population of 550 000 people living in the Cork region of Ireland. A total of 10 134 urine samples resulted in significant growth and received AST investigation. The significant isolates that caused UTIs were: 8999 Enterobacteriaceae (following deduplication 8355 isolates were included in this study); 225 non-Enterobacteriaceae Gramnegative bacilli; and 910 Gram-positive cocci. All significant Enterobacteriaceae were subject to AST investigation using a set of six first-line antimicrobial agents: ampicillin, amoxicillin/clavulanate, cefalexin, ciprofloxacin, nitrofurantoin and trimethoprim (n " 8355). It should be noted that when predetermined resistance patterns were observed, further investigation was completed to determine the presence of key antimicrobial resistance mechanisms and further AST for intravenous antimicrobial options was completed, but these are not reported in the current paper.
In order to observe resistance rates in different patient settings, the samples were categorized into three patient types based on origin, i.e. hospital inpatients, patients in long-term care facilities (LTCF patients) and a group representing all other nonhospitalized patients (NH patients), including General Practitioner, Outpatient Department and Emergency Department patients ( Table 1 ). The patient breakdown observed was 8.1% hospital inpatients, 6.0% LTCF patients and 85.9% NH patients. The gender breakdown observed was 85.4% female, 14.3% male and 0.3% unspecified gender.
Data analysis based on patient age was completed to allow comparison of resistance rates observed in three different age groups for which empirical treatment guidelines exist. The three age groups considered were ,17 years, 17-65 years and .65 years old (Table 1) .
Patients ,17 years old: UTI was detected in 629 urine samples. The average age for this group was 5.65 years. The gender breakdown observed was 497 female patients and 132 male patients.
Patient types observed were 585 NH patients and 44 hospital inpatients. There were no LTCF patients.
Patients 17-65 years old: UTI was detected in 3608 urine samples. The average age for this group was 43.86 years. The gender breakdown observed was 3215 female, 380 male and 13 of unspecified gender. Patient types observed were 3438 NH patients, 129 hospital inpatients and 41 LTCF patients.
Patients .65 years old: UTI was detected in 4118 urine samples. The average age for this group was 79.02 years. The gender breakdown observed was 3423 female patients, 685 male patients and 10 patients with unspecified gender. Patient types observed were 3156 NH patients, 503 hospital inpatients and 459 LTCF patients.
Discussion
Empirical treatment attempts to balance two important considerations, i.e. that failure to appropriately treat infection is associated with morbidity and mortality and that superfluous or inappropriate antimicrobial treatment is associated with development of antimicrobial resistance. 5, 6 It is believed that the use of antimicrobial agents that demonstrate resistance rates of 10%-20% leads to selection of resistant strains and increases the risk of treatment failure. 7 Clinical and mathematical studies for trimethoprim suggest that a resistance rate .20% is the level at which an antimicrobial agent is no longer suitable for empirical treatment of UTIs. [8] [9] [10] The American Congress of Obstetricians and Gynecologists recommend that when treating UTIs in non-pregnant adult women a change in antimicrobial class is required when resistance rates of 10%-15% are observed. 11 On consideration of these studies it may be suggested that a resistance rate of 20% is the maximum acceptable resistance rate at which an antimicrobial agent should be used as an empirical treatment option. This study concentrates on antimicrobial resistance rates observed in the Cork area of Ireland and therefore these resistance rates were used to assess the suitability of a set of Irish empirical treatment guidelines, i.e. those provided by the Health Service Executive (HSE) of Ireland. 12 Ampicillin is included as an empirical treatment option for children; however, the resistance rate observed in this study exceeds 55% for all patients ,17 years old thereby suggesting this is not a suitable form of empirical treatment (Table 1) . Amoxicillin/clavulanate is recommended for the treatment of pyelonephritis but the resistance rates observed here hover close to, or above, 20% for all patients (Table 1) , which suggests it may need to be excluded as an empirical treatment option. Ciprofloxacin appears to be a viable empirical treatment option for many patient categories (Table 1) ; however, some studies have mooted that where resistance rates exceed 10% ciprofloxacin should not be used empirically. 8, 13 Cefalexin is recommended for a number of different patient types and in light of the resistance rates observed this remains a viable empirical treatment option for all but LTCF patients who are .65 years old ( Table 1 ). The resistance rates observed for nitrofurantoin were consistently below 20% (Table 1) ; however, this is indicated for treatment of lower UTIs where there is no renal impairment, therefore limiting its suitability for some patients. 14 The empirical treatment guidelines provided by the HSE of Ireland recommend trimethoprim as a firstline empirical treatment option for all patients (with the exception of pregnant women); however, the resistance rates observed for Empirical treatment of urinary tract infections JAC this agent exceeded 25% for all but inpatients ,17 years old (Table 1) , therefore it may be considered unsuitable as an empirical treatment option for all other patients. The results of this study are limited geographically; however, similar assessment elsewhere can be completed using local resistance data and empirical treatment guidelines. In summary, a high level of resistance to commonly recommended empirical treatment options was observed across all patient categories included in this study. This clearly demonstrates that dependence on empirical treatment guidelines alone when considering treatment for UTIs is not appropriate. In order to preserve the usefulness of commonly prescribed antimicrobial agents and avoid selection of antimicrobial-resistant isolates it may be necessary to recast existing empirical treatment guidelines on the basis of resistance rates observed in the geographical area of interest. Indeed, we argue that the current focus on antimicrobial susceptibility when drafting empirical treatment guidelines may inadvertently camouflage the rate of antimicrobial resistance observed in Enterobacteriaceae-caused UTIs. As recently highlighted by Mayor 15 , the National Institute for Health and Care Excellence (NICE) draft guidelines acknowledge the need for culture to inform treatment of lower UTIs and suggest that immediate treatment should be provided only where symptoms are severe or the risk of complication is high. 16 This study supports this approach and emphasizes the need for collection of a urine sample before commencement of treatment, where possible, to enable completion of a pre-emptive culture to ensure evidence-based AST results are available to aid selection of an alternative treatment option should empirical treatment fail.
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